Here, we review the mechanism(s) of action of erlotinib ... line carboplatin–paclitaxel (TRIBUTE trial) or cisplatin–gemcitabine (TALENT trial). Erlotinib in a Phase III, randomized, placebo ...

The molecular basis and mechanisms of action of combining classic cytotoxic agents (e.g. platinum-containing drugs, taxanes, etc.) and novel agents (e.g. tirapazamine, EGFR inhibitors and other ...

Notes payable, plus accrued interest, totaled approximately $6.9 million. The current portion of the notes payable plus accrued interest totaled approximately $3.7 million. Included in the current ...